Reports
Sale
Asia Pacific Veterinary Vaccines Market Size, Share, Analysis: By Vaccine Type: Livestock Vaccines, Companion Animal Vaccines, Others; By Route of Administration: Oral, Parenteral, Others; By Distribution Channels; Regional Analysis; Market Dynamics; Competitive Landscape; Key Trends and Developments in the Market; 2024-2032
Asia Pacific Veterinary Vaccines Market Size
The market size for veterinary vaccines in the Asia Pacific reached a value of more than USD 2.06 billion in 2023. The Asia Pacific veterinary vaccines market is expected to grow at a CAGR of 6.6% between 2024 and 2032, reaching a value of USD 3.66 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Key Trends in the Market
Veterinary vaccines are specialised vaccines designed for animals to protect them against diseases or infections that they may be susceptible to. Veterinary vaccines with living organisms are preferred because they give the best protective response over purified antigens which are incapable of growing and spreading in the host.
Asia has a large number of livestock such as pigs, poultry, and cattle, which has opened opportunities for the Asia Pacific veterinary vaccines market to grow. Extreme care and protection from a number of diseases is required to avoid loss in business.
Government agencies across multiple countries in the region are taking up steps for the protection of animals and preventing the spread of diseases. They are carrying out campaigns informing people of diseases and vaccination programmes for farm animals and pets.
Key players are investing their time and money in research and development for new oral as well as parental techniques to inject vaccines in domestic and wild animals in order to encourage a healthy lifestyle in animals and prevent diseases that may be transmitted to humans.
Asia Pacific Veterinary Vaccines Market Analysis
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on vaccine type, the Asia Pacific veterinary vaccines market can be divided into livestock vaccines, companion animal vaccines, and other types of vaccines. Livestock vaccines are further subdivided into porcine vaccines, bovine vaccines, and poultry vaccines, among others, while companion animal vaccines are subdivided into canine vaccines, feline vaccines, and equine vaccines, among others.
On the basis of route of administration, the market is divided into oral, parenteral, and others. By distributional channel, the market is segmented into veterinary hospitals and clinics, pharmacies and drug stores, and online, among others. Based on country, the market is segmented into China, Japan, India, South Korea, Indonesia, Thailand, and Australia, among others.
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the Asia Pacific veterinary vaccines market covering their competitive landscape and latest developments like mergers, acquisitions, investments and expansion plans.
- Boehringer Ingelheim International GmbH
- Elanco Animal Health Inc.
- Zoetis Services LLC
- Merck & Co., Inc.
- Ceva Sante Animale
- Hester Biosciences Limited
- QYH Biotech Co., Ltd.
- Kyoto Biken Laboratories, Inc.
- PT JAPFA COMFEED INDONESIA Tbk
- Medion Farma
- Zuellig Pharma Limited
- PT Kalbe Farma Tbk
- Others
Market Share by Vaccine Type
Livestock vaccines account for a leading share in the Asia Pacific veterinary vaccines market due to the vast presence of livestock. With specialised vaccines available based on the animal type, they are an easy way to prevent illnesses in animals such as cattle, pigs, and poultry. Unexpected illnesses can spread quickly among livestock, causing significant loss of life and damage to the earning potential of the owners. Rapid spread of diseases amongst animals increases the risk of mutations, which may affect humans.
Although there is an increase in the number of companion animals adopted by people in the Asia Pacific as pets, the number of pets remains relatively lower as compared to other countries and regions. With growing awareness regarding the health of pets, and government regulations requiring vaccinations of pets, the companion animals segment is expected to witness steady growth in the coming years.
Market Share by Route of Administration
Vaccines in animals is commonly administered by injecting the vaccines in them through their skin in a mode commonly known as parenteral vaccination. Injecting vaccines offers multiple benefits, including confirmation that the vaccine has been administered effectively as animals may spit out oral vaccines. Due to the ease and accuracy of vaccine injections, parenteral administration holds a significant share in the Asia Pacific veterinary vaccines market.
Oral vaccinations, in comparison, are often preferred for companion animals as the pet owners can monitor administration and there is less stress on the animal. With time, there are new developments into other methods of vaccination, including through food and mucosal vaccination which are proving efficient and are expected to increase in demand in the coming years.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Competitive Landscape of Asia Pacific Veterinary Vaccines Industry
Boehringer Ingelheim International GmbH is a research-based pharmaceutical company which manufactures and delivers healthcare products such as medicines and vaccines. It was founded in 1885 and its headquarter is situated in Germany.
Elanco Animal Health Inc. is a pharmaceutical company which has its headquarters in Indiana, United States. It was found in 1954 with an aim to deliver vaccines and medicines for pets and domestic animals.
Zoetis Services LLC established in 1952 is a healthcare company founded specifically for animal care. It is based out of New Jersey, United States and has a strong presence in the Asia Pacific veterinary vaccines market. They serve their consumers with the premium quality vaccines, medicines, and diagnostic products.
Other market players include Merck & Co., Inc., Ceva Sante Animale, Hester Biosciences Limited, QYH Biotech Co., Ltd., Kyoto Biken Laboratories, Inc., PT JAPFA COMFEED INDONESIA Tbk, Medion Farma, Zuellig Pharma Limited, and PT Kalbe Farma Tbk, among others.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2018-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Vaccine Type |
|
| Breakup by Route of Administration |
|
| Breakup by Distribution Channels |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Market Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
7 Industry Opportunities and Challenges
8 Asia Pacific Veterinary Vaccines Market Analysis
8.1 Key Industry Highlights
8.2 Asia Pacific Veterinary Vaccines Historical Market (2018-2023)
8.3 Asia Pacific Veterinary Vaccines Market Forecast (2024-2032)
8.4 Asia Pacific Veterinary Vaccines Market by Vaccine Type
8.4.1 Livestock Vaccines
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2023)
8.4.1.3 Forecast Trend (2024-2032)
8.4.1.4 Breakup by Type
8.4.1.4.1 Porcine Vaccines
8.4.1.4.2 Bovine Vaccines
8.4.1.4.3 Poultry Vaccines
8.4.1.4.4 Others
8.4.2 Companion Animal Vaccines
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2023)
8.4.2.3 Forecast Trend (2024-2032)
8.4.2.4 Breakup by Type
8.4.2.4.1 Canine Vaccines
8.4.2.4.2 Feline Vaccines
8.4.2.4.3 Equine Vaccines
8.4.2.4.4 Others
8.4.3 Others
8.5 Asia Pacific Veterinary Vaccines Market by Route of Administration
8.5.1 Oral
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2023)
8.5.1.3 Forecast Trend (2024-2032)
8.5.2 Parenteral
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2023)
8.5.2.3 Forecast Trend (2024-2032)
8.5.3 Others
8.6 Asia Pacific Veterinary Vaccines Market by Distribution Channels
8.6.1 Veterinary Hospitals and Clinics
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2023)
8.6.1.3 Forecast Trend (2024-2032)
8.6.2 Pharmacies and Drug Stores
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2023)
8.6.2.3 Forecast Trend (2024-2032)
8.6.3 Online
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2018-2023)
8.6.3.3 Forecast Trend (2024-2032)
8.6.4 Others
8.7 Asia Pacific Veterinary Vaccines Market by Country
8.7.1 Market Share
8.7.1.1 China
8.7.1.2 Japan
8.7.1.3 India
8.7.1.4 South Korea
8.7.1.5 Indonesia
8.7.1.6 Thailand
8.7.1.7 Australia
8.7.1.8 Others
9 Regional Analysis
9.1 China
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Japan
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
9.3 India
9.3.1 Historical Trend (2018-2023)
9.3.2 Forecast Trend (2024-2032)
9.4 South Korea
9.4.1 Historical Trend (2018-2023)
9.4.2 Forecast Trend (2024-2032)
9.5 Indonesia
9.5.1 Historical Trend (2018-2023)
9.5.2 Forecast Trend (2024-2032)
9.6 Thailand
9.6.1 Historical Trend (2018-2023)
9.6.2 Forecast Trend (2024-2032)
9.7 Australia
9.7.1 Historical Trend (2018-2023)
9.7.2 Forecast Trend (2024-2032)
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 Boehringer Ingelheim International GmbH
11.2.1.1 Company Overview
11.2.1.2 Product Portfolio
11.2.1.3 Demographic Reach and Achievements
11.2.1.4 Certifications
11.2.2 Elanco Animal Health Inc
11.2.2.1 Company Overview
11.2.2.2 Product Portfolio
11.2.2.3 Demographic Reach and Achievements
11.2.2.4 Certifications
11.2.3 Zoetis Services LLC
11.2.3.1 Company Overview
11.2.3.2 Product Portfolio
11.2.3.3 Demographic Reach and Achievements
11.2.3.4 Certifications
11.2.4 Merck & Co., Inc.
11.2.4.1 Company Overview
11.2.4.2 Product Portfolio
11.2.4.3 Demographic Reach and Achievements
11.2.4.4 Certifications
11.2.5 Ceva Santé Animale
11.2.5.1 Company Overview
11.2.5.2 Product Portfolio
11.2.5.3 Demographic Reach and Achievements
11.2.5.4 Certifications
11.2.6 Hester Biosciences Limited
11.2.6.1 Company Overview
11.2.6.2 Product Portfolio
11.2.6.3 Demographic Reach and Achievements
11.2.6.4 Certifications
11.2.7 QYH Biotech Co., Ltd.
11.2.7.1 Company Overview
11.2.7.2 Product Portfolio
11.2.7.3 Demographic Reach and Achievements
11.2.7.4 Certifications
11.2.8 Kyoto Biken Laboratories, Inc.
11.2.8.1 Company Overview
11.2.8.2 Product Portfolio
11.2.8.3 Demographic Reach and Achievements
11.2.8.4 Certifications
11.2.9 PT JAPFA COMFEED INDONESIA Tbk.
11.2.9.1 Company Overview
11.2.9.2 Product Portfolio
11.2.9.3 Demographic Reach and Achievements
11.2.9.4 Certifications
11.2.10 Medion Farma
11.2.10.1 Company Overview
11.2.10.2 Product Portfolio
11.2.10.3 Demographic Reach and Achievements
11.2.10.4 Certifications
11.2.11 Zuellig Pharma Limited
11.2.11.1 Company Overview
11.2.11.2 Product Portfolio
11.2.11.3 Demographic Reach and Achievements
11.2.11.4 Certifications
11.2.12 PT Kalbe Farma Tbk.
11.2.12.1 Company Overview
11.2.12.2 Product Portfolio
11.2.12.3 Demographic Reach and Achievements
11.2.12.4 Certifications
11.2.13 Others
12 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Asia Pacific Veterinary Vaccine Market: Key Industry Highlights, 2018 and 2032
2. Asia Pacific Veterinary Vaccine Historical Market: Breakup by Vaccine Type (USD Million), 2018-2023
3. Asia Pacific Veterinary Vaccine Market Forecast: Breakup by Vaccine Type (USD Million), 2024-2032
4. Asia Pacific Veterinary Vaccine Historical Market: Breakup by Route of Administration (USD Million), 2018-2023
5. Asia Pacific Veterinary Vaccine Market Forecast: Breakup by Route of Administration (USD Million), 2024-2032
6. Asia Pacific Veterinary Vaccine Historical Market: Breakup by Distribution Channels (USD Million), 2018-2023
7. Asia Pacific Veterinary Vaccine Market Forecast: Breakup by Distribution Channels (USD Million), 2024-2032
8. Asia Pacific Veterinary Vaccine Historical Market: Breakup by Country (USD Million), 2018-2023
9. Asia Pacific Veterinary Vaccine Market Forecast: Breakup by Country (USD Million), 2024-2032
10. Asia Pacific Veterinary Vaccine Market Structure
Key Questions Answered in the Report
The market size for veterinary vaccines in the Asia Pacific reached a value of more than USD 2.06 billion in 2023.
The market is expected to grow at a CAGR of 6.60% between 2024 and 2032.
The major market drivers are increase in awareness, developments in vaccines, and inclination towards adoption of pets.
The size for veterinary vaccines market in the Asia Pacific is expected to reach a value of more than USD 3.66 billion in 2032.
The key trends of the market are large numbers of livestock, steps by government agencies to encourage animal vaccination, and research and developments in vaccine technology and administration modes.
Key market players include Boehringer Ingelheim International GmbH, Elanco Animal Health Inc., Zoetis Services LLC, Merck & Co., Inc., Ceva Sante Animale, Hester Biosciences Limited, QYH Biotech Co., Ltd., Kyoto Biken Laboratories, Inc., PT JAPFA COMFEED INDONESIA Tbk, Medion Farma, Zuellig Pharma Limited, and PT Kalbe Farma Tbk, among others.
Veterinary vaccines are specialised vaccines given to animals in order to protect them against diseases or infections they may be susceptible to.
The Asia Pacific veterinary vaccines market is segmented based on vaccine type, route of administration, distribution channel, and country.
Veterinary vaccines with living organisms are preferred because they give the best protective response over purified antigens which are incapable of growing and spreading in the host.
The key distributional channels in the market are veterinary hospitals and clinics, pharmacies and drug stores, and online, among others.
Purchase Options 10% off
Call us
Purchase Full Report
Datasheet
$ 2199
$1999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 3299
$2999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 4399
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 5499
$4999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER